Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Ruixun Biotech logo — Merging innovation and precision to advance molecular diagno...

Ruixun Biotech

Merging innovation and precision to advance molecular diagnosis and genetic testing.

Founded 2017 51-200 employees Series C Total: $1.95M Biotechnology, Health Care

General Information

Company Name Ruixun Biotech
Founded Year 2017
Employees 51-200
Industries Biotechnology, Health Care
Funding Stage Series C
Social

BounceWatch is an independent company data service, not affiliated with Ruixun Biotech. To contact Ruixun Biotech, visit rainsurebio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Ruixun Biotech compare?

A PDF of Ruixun Biotech and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Ruixun Biotech soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Ruixun Biotech

Ruixun Biotech is a healthcare company that specializes in biotechnology, aiming to merge innovation and precision to advance molecular diagnosis and genetic testing. Founded in 2017, the company integrates microfluidics, optics, precision instruments, electronic engineering, and biochemical technologies to develop upstream equipment and consumables for molecular diagnosis and genetic testing. Its product lineup includes the digital PCR apparatus DropX-2000 and over 50 different RUO detection kits.

The latest milestone for Ruixun Biotech was the Series C investment at 17 November 2022, with funding from Kaitai Capital and Qiandao Fund. With a focus on advancing healthcare through cutting-edge biotechnology, Ruixun Biotech presents a promising venture for investors seeking opportunities in the Biotechnology and Health Care industries.

Business keywords: molecular diagnosis, genetic testing, microfluidics, optics, precision instruments, electronic engineering, biochemical technologies, digital PCR, RUO detection kits, diagnostic kits, real-time PCR system, consumables

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Series C Undisclosed 2
Kaitai Capital
Kaitai Capital, Qiandao Fund
17 Nov 2022
Series A Undisclosed 4
Future Capital Volcanics Venture
Future Capital, Volcanics Venture +2
26 Sep 2019
Seed Round $1.95M 4
ZhenFund FutureCap Volcanics Venture
ZhenFund, FutureCap +2
17 Jul 2018
Angel Round Undisclosed -
20 Nov 2017

Ruixun Biotech Alternatives & Competitors

View All Alternatives
Ruixun Biotech vs
Suzhou Molarray Co., Ltd.
Suzhou Molarray Co., Ltd. China

Amid the fight against the COVID-19 pandemic, Molarray's PCR machines are used to help detect and id...

Venture round
4 employees
Biotechnology, Health Care
Ruixun Biotech vs
Isogen Life Science
Isogen Life Science The Netherlands

Making your research happen. From sample to result.

21 employees
Biotechnology, Health Care
Ruixun Biotech vs
xMD Diagnostics, Inc.
xMD Diagnostics, Inc. United States

Enabling precision diagnostics

Non Equity Assistance
2 employees
Biotechnology, Health Care
View all alternatives

FAQ About Ruixun Biotech

Merging innovation and precision to advance molecular diagnosis and genetic testing.
Ruixun Biotech was founded in 2017.
Ruixun Biotech operates in Biotechnology and Health Care. Its work centres on molecular diagnosis, genetic testing, microfluidics and optics.
Ruixun Biotech has approximately 51-200 employees.
Ruixun Biotech has completed 4 funding rounds, raising a total of $1.95M. The latest funding stage is Series C.
Top alternatives and competitors to Ruixun Biotech include Suzhou Molarray Co., Ltd., Isogen Life Science, xMD Diagnostics, Inc., FRIZ Biochem GmbH, Advanced Molecular Diagnostics Ltd.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Ruixun Biotech and Suzhou Molarray Co., Ltd. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Ruixun Biotech, https://bouncewatch.com/company/ruixun-biotech, updated 24 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout